DVS Edition Citation

Hatton, C. K., Green, G. A. & Ambrose, P. J. (2014). Performance-enhancing drugs: Understanding the risks. Physical Medicine & Rehabilitation Clinics of North America, 25 (4), 897-913. Zugriff am 05.08.2019 unter https://doi.org/10.1016/j.pmr.2014.06.013

APA (7th ed.) Citation

Hatton, C. K., Green, G. A., & Ambrose, P. J. (2014). Performance-enhancing drugs: Understanding the risks. Physical Medicine & Rehabilitation Clinics of North America, 25(4), 897-913.

Chicago Style (17th ed.) Citation

Hatton, C. K., G. A. Green, and P. J. Ambrose. "Performance-enhancing Drugs: Understanding the Risks." Physical Medicine & Rehabilitation Clinics of North America 25, no. 4 (2014): 897-913.

MLA (9th ed.) Citation

Hatton, C. K., et al. "Performance-enhancing Drugs: Understanding the Risks." Physical Medicine & Rehabilitation Clinics of North America, vol. 25, no. 4, 2014, pp. 897-913.